Fingerprint
Dive into the research topics of 'Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines
Wei Zhang, Michael Peyton, Yang Xie, Junichi Soh, John D. Minna, Adi F. Gazdar, Eugene P. Frenkel
Research output: Contribution to journal › Article › peer-review
60
Scopus
citations